143 related articles for article (PubMed ID: 17219976)
1. Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer.
Li J; Hong M; Pan T
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):587-90. PubMed ID: 17219976
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
3. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].
Dong X; Qiu XS; Wang EH; Li QC; Gu W
Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):128-32. PubMed ID: 12839674
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
6. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
Li Q; Dong X; Gu W; Qiu X; Wang E
Chin Med J (Engl); 2003 May; 116(5):727-30. PubMed ID: 12875690
[TBL] [Abstract][Full Text] [Related]
10. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.
Kitano H; Chung JY; Noh KH; Lee YH; Kim TW; Lee SH; Eo SH; Cho HJ; Choi CH; Inoue S; Hanaoka J; Fukuoka J; Hewitt SM
J Transl Med; 2017 Jun; 15(1):138. PubMed ID: 28623914
[TBL] [Abstract][Full Text] [Related]
11. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.
Han FH; Li HM; Zheng DH; He YL; Zhan WH
Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
Eroğlu A; Ersöz C; Karasoy D; Sak S
Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
15. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Enatsu S; Kawakami T; Kuroki M; Kuroki M
Anticancer Res; 2007; 27(6A):3735-41. PubMed ID: 17970036
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.
Bi MM; Shang B; Wang Z; Chen G
Thorac Cancer; 2017 Nov; 8(6):634-641. PubMed ID: 28925100
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer.
Li M; Chen H; Diao L; Zhang Y; Xia C; Yang F
Tumori; 2010; 96(5):734-43. PubMed ID: 21302621
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.
Donnem T; Al-Shibli K; Al-Saad S; Delghandi MP; Busund LT; Bremnes RM
Lung Cancer; 2009 Feb; 63(2):277-83. PubMed ID: 18599153
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical implication of HIF-1alpha and VEGF-C in non-small cell lung cancer.
Zuo S; Ji Y; Wang J; Guo J
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):674-6. PubMed ID: 19107364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
